Perioperative Low Carb Diet in a Type 2 Diabetic Prior Duodenopacreatectomy

Perioperative Low Carb Diet in a Type 2 Diabetic Prior Duodenopacreatectomy

Dário Vianna Birolini; Eduardo Rissi; Gustavo Souto Rachid Hatun

Department of General Surgery. Vivalle Rede D’or Hospital, São José Dos Campos – SP – Brazil. Av. Linneu de Moura, 995 – Urbanova – ZIP 12244-380

Background: There is a positive association between various types of cancer and diabetes. Duodenopancreatectomy is the treatment of choice for diabetic patients with duodenal tumors. Pancreatic resections may trigger endocrine insufficiency. There is an association between poor glycemic control and lower survival rates. Low carb diets appears to be an effective approach in the treatment of diabetic patients that require pancreatic resections.

Case Presentation: We report the case of a type II diabetic diagnosed with resectable duodenum cancer. At the time of diagnosis he was jaundiced and with decompensated diabetes. The patient was submitted to a low carb diet for three weeks and, having improved its physiological and metabolic parameters, we performed a duodenopancreatectomy. The patient evolved without complications, with easy management of postoperative glycemia.

Conclusions: Low carb diets can prove to be a powerful, inexpensive, and safe tool to add to our therapeutic arsenal before pancreatic resections.

Keywords: Pancreatectomy, ketogenic diet, duodenal carcinoma, type 2 diabetes, pancreatic endocrine insufficiency

Free Full-text PDF

How to cite this article:

Dário Vianna Birolini; Eduardo Rissi; Gustavo Souto Rachid Hatun . Perioperative Low Carb Diet in a Type 2 Diabetic Prior Duodenopacreatectom. International Journal of Case Reports, 2022, 6:266. DOI: 10.28933/ijcr-2022-1-1705

References:

1. Sun Ha Jee; Heechoul Ohrr; Jae Woong Sull; et al. Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women, JAMA. 2005;293(2):194-202. doi:10.1001/jama.293.2.194
2. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev. 2000; 21:215-244. doi: 10.1210/edrv.21.3.0399
3. La Vecchia C, Negri E, DeCarli A, Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer. 1997;73:204-207. doi: 10.1002/(sici)1097-0215(19971009)73:2%3C204::aid-ijc7%3E3.0.co;2-#
4. Weiderpass E, Gridley G, Persson I, Nyren O, Ek- bom A, Adami HO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer. 1997; 71:360-363. DOI: 10.1002/(sici)1097-0215(19971009)73:2<204::aid-ijc7>3.0.co;2-#
5. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999; 91:542-547. DOI: 10.1093/jnci/91.6.542
6. Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015 Jan 2;350:g7371. doi: 10.1136/bmj.g7371
7. Cheng XD, Du YA, Xu ZY, Huang L, Yang LT, Wang B, et al. A Modified Pancreaticojejunostomy: Kissing Pancreaticojejunostomy. Hepatogastroenterology 21 2011; 59. doi: 10.5754/hge11291.
8. Kusakabe J, Anderson B, Liu J, Williams GA, Chapman WC, Doyle MMB, et al. Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy. J Gastrointest Surg. 2019 August ; 23(8): 1604–1613. doi:10.1007/s11605-018-04084-x.
9. Michael J. Ferrara, Christine Lohse, Yogish C. Kudva, Michael B. Farnell, Florencia G. Que, et al. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013 Mar;15(3):170-4. doi: 10.1111/j.1477-2574.2012.00520.x
10. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552-2558. DOI: 10.1001/jama.283.19.2552
11. Bal A, Joshi K, Vaiphei K, Wig JD. Primary duodenal neoplasms: a retrospective clinico-pathological analysis. World J Gastroenterol 2007; 13: 1108-1111. doi: 10.3748/wjg.v13.i7.1108
12. (ref https://www.cdc.gov/nchs/data/databriefs/db288.pdf)
13. (ref https://www.cdc.gov/diabetes/data/statistics/statistics-report.html)
14. Chung WC, Paik CN, Jung SH, Lee KM, Kim SW, Chang UI, et al. Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med 2011; 26: 34-40. doi: 10.3904/kjim.2011.26.1.34
15. Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH. The surgical 16 treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 2010; 41: 243-247. doi: 10.1007/s12029-010-9160-1
16. Sista F, De Santis G, Giuliani A, Cecilia EM, Piccione F, Lancione L, et al. Adenocarcinoma of the third duodenal portion: Case report and review of literature. World J Gastrointest Surg 2012; 4(1): 23-26. doi: 10.4240/wjgs.v4.i1.23
17. Harsha Moole, Matthew Bechtold, and Srinivas R. Puli. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol. 2016; 14: 182. doi: 10.1186/s12957-016-0933-2
18. Athinarayanan SJ, Adams RN, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, et al. (2019) Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial. Front. Endocrinol. 10:348. doi: 10.3389/fendo.2019.00348
19. Eric C. Westman, Justin Tondt, Emily Maguire & William S. Yancy Jr. (2018): Implementing a low carbohydrate, ketogenic diet to manage type 2 diabetes mellitus, Expert Review of Endocrinology & Metabolism, DOI: 10.1080/17446651.2018.1523713
20. Hussain TA1, Mathew TC, Dashti AA, Asfar S, Al-Zaid N, Dashti HM. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition. 2012 Oct;28(10):1016-21. doi: 10.1016/j.nut.2012.01.016
21. William S Yancy Jr, Marjorie Foy, Allison M Chalecki, Mary C Vernon and Eric C Westman A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond). 2005; 2: 34. doi: 10.1186/1743-7075-2-34
22. Turton J, Brinkworth GD, Field R, Parker H, Rooney K. An evidence-based approach to developing low-carbohydrate diets for type 2 diabetes management: A systematic review of interventions and methods. Diabetes Obes Metab. 2019;1–13. https://doi.org/ 10.1111/dom.13837
23. McKenzie AL, Hallberg SJ, Creighton BC, Volk BM, Link TM, Abner MK, et al. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes. JMIR Diabetes 2017;2(1):e5 doi: 10.2196/diabetes.6981.
24. Grajower MM1, Horne BD. Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus. Nutrients. 2019 Apr 18;11(4). pii: E873. doi: 10.3390/nu11040873
25. Unwin Dj, Tobin SD, Murray Sw, Delon C and Brady AJ. Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care. Int. J. Environ. Res. Public Health 2019, 16, 2680; doi:10.3390/ijerph16152680
26. Friedman AN, Ogden LG, Foster GD, Klein S, Stein R, Miller B, et al. Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol. 2012 Jul; 7(7): 1103–1111. doi: 10.2215/CJN.11741111
27. Cahill GF. Fuel metabolism in starvation. Annu. Rev. Nutr. 2006. 26:1–22 doi: 10.1146/annurev.nutr.26.061505.111258 27- Cahill é o mesmo do 29 e do 30
28. Phinney SD, Bistrian BR, Wolfe RR, Blackburn GL. The human metabolic response to chronic ketosis without caloric restriction: physical and biochemical adaptation. Metabolism. 1983 Aug;32(8):757-68. DOI: 10.1016/0026-0495(83)90105-1
29. Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer & Metabolism 2014, 2:18. doi: 10.1186/2049-3002-2-18
30. Ok JH, Lee H, Chung HY, Lee SH, Choi EJ, Kang CM, et al. The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy. ANTICANCER RESEARCH 38: 6519-6527 (2018) doi:10.21873/anticanres.13017
31. Zahra A, Fath MA, Opat E, Mapuskar KA, Bhatia SK, Ma DC, et al. Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials.. Radiat Res. 2017 June ; 187(6): 743–754. doi:10.1667/RR14668.1.
32. Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biology 2 (2014) 963–970. doi: 10.1016/j.redox.2014.08.002
33. Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer e Where do we stand? Mol Metab. 2019 Jul 27. pii: S2212-8778(19)30427-2. https://doi.org/10.1016/j.molmet.2019.06.026